Buy Shire (SHPG) on Deal Weakness, BofA/Merrill Lynch Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
SunTrust Upgrades Shire (SHPG) to Buy
October 20, 2014 8:31 AM EDTSunTrust Robinson Humphrey upgraded Shire (NASDAQ: SHPG) from Neutral to Buy with a price target of $225.00.
For an analyst ratings summary and ratings history on Shire click here. For more ratings news on Shire click here.
Shares of Shire closed at $179.16 yesterday.
... MoreAbbVie (ABBV) Board Recommends Voting Against Shire (SHPG) Transaction
October 16, 2014 6:27 AM EDTAbbVie (NYSE: ABBV) announced its Board of Directors' withdraws its recommendation made on July 18, 2014 regarding the proposed Shire (NASDAQ: SHPG) transaction and recommends that stockholders vote against the transaction.
AbbVie and its Board of Directors made this determination following a detailed consideration of the impact of the U.S. Department of Treasury's unilateral changes to the tax rules, as issued on September 22, 2014. The breadth and scope of the changes, including the unexpected nature of the exercise of administrative authority to impact longstanding tax principles, and to target... More
Shire (SHPG) Waives 3 Day Notice for AbbVie (ABBV) Board Meeting
October 15, 2014 1:49 PM EDTShire (NASDAQ: SHPG) announces that, in order to allow the period of uncertainty for its shareholders, employees and other stakeholders to be reduced, it has agreed to waive the requirement for three business days' notice for AbbVie's (NYSE:... More
